Zydus Lifesciences bags US FDA approval for Sildenafil for Oral Suspension
The drug will be manufactured at the group’s formulation manufacturing facility at Baddi, Himachal Pradesh
Quality / GMP | 03/10/2022 | By Sudeep Soparkar | 510
Lupin gets EIR from US FDA for its Ankleshwar facility
The inspection of the facility was conducted from August 16-19, 2022
Quality / GMP | 03/10/2022 | By Sudeep Soparkar | 1051
Zydus Lifesciences' Ahmedabad unit under USFDA observation
The inspection was conducted between September 23 to September 29, 2022
Quality / GMP | 30/09/2022 | By Sudeep Soparkar | 1137
Lupin's Tarapur facility receives warning letter from US FDA
The company believes that the warning letter will not affect supply disruptions or current revenues from this facility's operations
Quality / GMP | 29/09/2022 | By Sudeep Soparkar | 811
Torrent Pharma's Gujarat facility gets three observations from US FDA
The inspection was carried its manufacturing facility at Indrad, Gujarat from September 19, 2022, to September 28, 2022
<br />
Quality / GMP | 29/09/2022 | By Sudeep Soparkar | 561
Shilpa Medicare's plant in Telangana bags US FDA clearance
The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited (Parent Organization) and its agreed parties
Quality / GMP | 23/09/2022 | By Sudeep Soparkar | 1253
China API plant banned by FDA for having no quality control in place
The batch testing that was performed was done over and over again, and only some of the results were recorded
<br />
Quality / GMP | 11/08/2022 | By Sudeep Soparkar | 664
Strides Pharma successfully completes US FDA inspection at Singapore facility
The inspection was completed successfully with Zero 483 observations
Quality / GMP | 11/08/2022 | By Sudeep Soparkar | 1209
Smoke study during material transfer
We have to prove that laminar airflow is maintained in the filling machine while doing various activities in the filling machine. Let's find out what are these activities.
Quality / GMP | 10/05/2022 | By Sudeep Soparkar | 1204
Zydus under three observations from FDA
Indian-based pharma company Zydus Lifesciences just got hit with a triple whammy by the U.S. FDA.
Quality / GMP | 26/04/2022 | By Sudeep Soparkar | 735
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy